FDAnews Device Daily Bulletin

FDA APPROVES COVALON'S COLLAGRAN AND COLLAGRAN AG ADVANCED WOUND DRESSINGS

April 28, 2006
A A

Covalon Technologies Ltd. announces that the FDA has approved Covalon's proprietary Collagran and Collagran Ag new collagen-based wound dressings for use in the USA. The FDA approval of Covalon's proprietary collagen-based Collagran and its antimicrobial silver ion-releasing Collagran Ag wound dressings represents a significant milestone for the company. The new dressings, when applied to decubitus and other wounds, create a beneficial wound healing environment. CCN Matthews (http://www.ccnmatthews.com/news/releases/show.jsp?action=showRelease&searchText=false&showText=all&actionFor=591185)